Back to search

University of South Florida

From Cardiovascular Safety Assessment to Peptide Hemolytic Activity Prediction: Integrative Computational Analyses for Drug Evaluation and Discovery

Abstract

dc:description

This thesis applied integrative computational approaches to two major areas of drug evaluation and discovery: cardiovascular safety assessment and peptide hemolytic activity prediction. First, pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS), electronic health records (EHRs) from TriNetX, and transcriptomic analyses were combined to evaluate anesthetic-associated cardiac rhythm adverse drug events. Among propofol, ketamine, dexmedetomidine, and midazolam, dexmedetomidine showed the strongest association with bradycardia across both FAERS and propensity score-matched EHR analyses. Stratified analyses further suggested substantially higher bradycardia prevalence among older patients and a modestly increased risk among male patients. Drug-drug interaction analyses identified risperidone and albuterol as co-medications associated with increased bradycardia risk during dexmedetomidine exposure. Transcriptomic analyses provided supportive biological context, including downregulation of cardiac muscle contraction-related genes and identification of miR-26a-5p and miR-30c-5p as candidate regulators of heart-rate-related pathways. Second, a similar real-world data and transcriptomic framework was applied to compare cardiovascular adverse events associated with three COVID-19 therapies, remdesivir, Paxlovid, and REGEN-COV. Remdesivir showed the strongest and most consistent cardiovascular safety signals, particularly for bradycardia, hypotension, and cardiac arrest. Age-stratified analyses indicated distinct age-associated patterns, while transcriptomic analysis of remdesivir-treated cardiomyocytes identified enrichment of pathways related to cGMP-PKG signaling, calcium signaling, cardiac muscle contraction, and cardiomyopathy. Third, this thesis developed an interpretable XGBoost-based model to predict peptide hemolytic activity using sequence-derived physicochemical and mechanism-based features. The model achieved performance comparable to existing predictors while providing improved interpretability. Feature importance and correlation analyses highlighted hydrophobic patch count as a key sequence-level feature associated with hemolytic activity, suggesting that local hydrophobic organization may be more informative than global hydrophobicity alone. Overall, this thesis demonstrates the value of integrating real-world data, transcriptomics, and interpretable machine learning to identify clinically relevant safety signals and guide safer therapeutic design.

Degree

thesis:*
Name thesis:degree_name
Master of Science (M.S.)
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Pharmacy
Grantor
University of South Florida
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zhu, Xinran
Contributors dc:contributor
  • Feng Cheng, Ph.D.
  • Vijaykumar Sutariya, M.Pharm, Ph.D., R.Ph
  • Sheeba Varghese Gupta, M.Pharma, Ph.D.

Subjects

dc:subject × 7

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/11457

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Zhu, Xinran. From Cardiovascular Safety Assessment to Peptide Hemolytic Activity Prediction: Integrative Computational Analyses for Drug Evaluation and Discovery. Thesis thesis, University of South Florida, 2026. https://digitalcommons.usf.edu/etd/11457